Healthcare
NHS Innovation and Life Sciences Commission – 2022 Report La...
Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the
News
Sanofi drops BTK drug tolebrutinib in myasthenia gravis
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
Oncology
Sponsored
How can digital and AI optimise the delivery of patient supp...
How can digital and AI optimise the delivery of patient support programs in cancer?
Digital
Create, approve, deploy: supercharge comms with modular cont...
Each year, pharma and life sciences invest large amounts of time and money in creating content designed to attract HCPs and call them to action.
Sales & Marketing
Sponsored
Empowering MSLs to be the kings of Pharma’s New Frontier
The demand for high-calibre, sharply-focussed clinical knowledge and data is increasing as HCPs streamline and recalibrate their engagements with the pharmaceutical sector. But, al
White Papers
Sponsored
Sales coaching: preparing for the new reality in pharma
COVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an accelerant for progress in its use of digital technology and prompting a reassessme
Oncology
Partner Content
2nd Next Generation Kinase Inhibitors Summit
Industry-dedicated summit focused on advancing the best-in-class kinase inhibitor products
R&D
Partner Content
5th Cell Engager Summit
The 5th Annual Cell Engager Summit is back in Boston, MA this year
Category :
Views & Analysis
/
